Viking Global Investors Portfolio holdings
AUM
$34.6B
1-Year Return
30.14%
This Quarter Return
+5.56%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$30.9B
AUM Growth
+$3.46B
(+13%)
Cap. Flow
+$2.39B
Cap. Flow
% of AUM
7.73%
Top 10 Holdings %
Top 10 Hldgs %
35.93%
Holding
105
New
22
Increased
29
Reduced
26
Closed
19
Top Buys
| 1 |
UnitedHealth
UNH
|
+$961M |
| 2 |
Charles Schwab
SCHW
|
+$912M |
| 3 |
JPMorgan Chase
JPM
|
+$904M |
| 4 |
Intuit
INTU
|
+$898M |
| 5 |
TSMC
TSM
|
+$808M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.13B |
| 2 |
Workday
WDAY
|
+$799M |
| 3 |
Adobe
ADBE
|
+$617M |
| 4 |
Atlassian
TEAM
|
+$603M |
| 5 |
Philip Morris
PM
|
+$477M |
Sector Composition
| 1 | Financials | 29.43% |
| 2 | Technology | 19.81% |
| 3 | Healthcare | 16.68% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Equitable Holdings
EQH
$16.2B
| $36.1M | 0.12% |
764,323
-2,285,939
| -75% | -$108M |
|
77
Oric Pharmaceuticals
ORIC
$1.05B
| $35.8M | 0.12% |
4,431,008
+431,008
| +11% | +$3.48M |
|
78
Ginkgo Bioworks
DNA
$593M
| $35.1M | 0.11% |
3,577,128
| – | – |
|
79
Immunovant
IMVT
$2.82B
| $34.9M | 0.11% |
1,407,290
-913,612
| -39% | -$22.6M |
|
80
Edgewise Therapeutics
EWTX
$1.5B
| $32.7M | 0.11% |
1,224,986
-256,160
| -17% | -$6.84M |
|
81
lululemon athletica
LULU
$19B
| $31.8M | 0.1% |
+83,105
| New | +$31.8M |
|
82
Inhibrx
INBX
$399M
| $27.5M | 0.09% |
1,787,705
| – | – |
|
83
Trevi Therapeutics
TRVI
$1B
| $18.1M | 0.06% |
4,400,000
| – | – |
|
|
PONY
84
Pony AI Inc. American Depositary Shares
PONY
$5.33B
| $10.6M | 0.03% |
+739,797
| New | +$10.6M |
|
85
PepGen
PEPG
$48.5M
| $5.62M | 0.02% |
1,482,434
| – | – |
|
86
Rallybio
RLYB
$25.1M
| $4.03M | 0.01% |
4,194,777
| – | – |
|
87
Viking Therapeutics
VKTX
$2.79B
| – | – |
-721,926
| Closed | -$45.7M |
|
|
88
Apple
AAPL
$3.47T
| – | – |
-4,859,142
| Closed | -$1.13B |
|
89
Acadia Healthcare
ACHC
$2.01B
| – | – |
-3,701,347
| Closed | -$235M |
|
90
Ameriprise Financial
AMP
$46.9B
| – | – |
-243,055
| Closed | -$114M |
|
91
CBRE Group
CBRE
$48.8B
| – | – |
-1,571,735
| Closed | -$196M |
|
92
Carnival Corp
CCL
$42.7B
| – | – |
-9,559,560
| Closed | -$177M |
|
93
Day One Biopharmaceuticals
DAWN
$729M
| – | – |
-2,558,563
| Closed | -$35.6M |
|
94
Freeport-McMoran
FCX
$64.2B
| – | – |
-3,140,964
| Closed | -$157M |
|
95
Eli Lilly
LLY
$677B
| – | – |
-152,038
| Closed | -$135M |
|
96
Las Vegas Sands
LVS
$36.7B
| – | – |
-8,665,215
| Closed | -$436M |
|
97
McDonald's
MCD
$218B
| – | – |
-1,120,649
| Closed | -$341M |
|
98
3M
MMM
$84.1B
| – | – |
-840,751
| Closed | -$115M |
|
99
Rogers Communications
RCI
$19.3B
| – | – |
-2,701,058
| Closed | -$109M |
|
100
Regeneron Pharmaceuticals
REGN
$59.4B
| – | – |
-49,870
| Closed | -$52.4M |
|